Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.
Biol. Blood Marrow Transplant., Jan;18(1):76-83 (2012)
A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast.
Plast. Reconstr. Surg., Sep;128(3):112e-118e (2011)
Chemotherapy is an effective first line treatment for early stage gastric mucosa-associated lymphoid tissue lymphoma.
Cancer Treat. Rev., Apr;32(2):139-43 (2006)
Primary CNS lymphoma.
Nat Clin Pract Neurol., Jan;3(1):24-35 (2007)
Bing-Neel Syndrome revisited.
Clin Lymphoma Myeloma., Mar;9(1):104-6 (2009)
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience.
Biol. Blood Marrow Transplant., Nov;15(11):1447-54 (2009)
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Am. J. Surg. Pathol., Mar;34(3):327-40 (2010)
Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Cancer., Aug;116(16):3835-42 (2010)
Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
Cancer., Sep;116(18):4283-90 (2010)
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.
Ann. Oncol., Apr;22(4):910-5 (2011)
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Ann. Oncol., Aug;22(8):1859-64 (2011)
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.
Clin. Cancer Res., May;17(9):2977-86 (2011)
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.
Blood., Aug;98(4):1116-21 (2001)
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Clin. Cancer Res., Jul;8(7):2052-60 (2002)
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.
Blood., Jan;101(1):363-9 (2003)
Quantitative monitoring of BCR/ABL transcript during STI-571 therapy.
Leuk. Lymphoma., Dec;43(12):2281-9 (2002)
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
Blood., Sep;102(5):1601-5 (2003)
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.
Blood., Jan;103(1):353-9 (2004)
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
Clin. Cancer Res., Aug;10(15):5065-71 (2004)
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
Bone Marrow Transplant., Dec;34(11):987-94 (2004)